1610737-02-4

Basic information

• Product Name: N-((1s,4s)-4-(2-(4'-((1,4-oxazepan-4-yl)methyl)biphenyl-3-yloxy)-5-fluoronicotinamido)cyclohexyl)-2-methylthiazole-4-carboxamide trifluoroacetic acid salt
• CAS NO: 1610737-02-4
• Molecular Weight: 757.806
• Mol File: 1610737-02-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-((1s,4s)-4-(2-(4'-((1,4-oxazepan-4-yl)methyl)biphenyl-3-yloxy)-5-fluoronicotinamido)cyclohexyl)-2-methylthiazole-4-carboxamide trifluoroacetic acid salt(CAS DataBase Reference)
• NIST Chemistry Reference: N-((1s,4s)-4-(2-(4'-((1,4-oxazepan-4-yl)methyl)biphenyl-3-yloxy)-5-fluoronicotinamido)cyclohexyl)-2-methylthiazole-4-carboxamide trifluoroacetic acid salt(1610737-02-4)
• EPA Substance Registry System: N-((1s,4s)-4-(2-(4'-((1,4-oxazepan-4-yl)methyl)biphenyl-3-yloxy)-5-fluoronicotinamido)cyclohexyl)-2-methylthiazole-4-carboxamide trifluoroacetic acid salt(1610737-02-4)

Safety Data

• Hazardous Substances Data: 1610737-02-4(Hazardous Substances Data)

Upstream product

• 1197013-81-2 N-((1s,4s)-4-aminocyclohexyl)-5-fluoro-2-(3-iodophenoxy)nicotinamide hydrochloride 
• 582333-07-1 tert-butyl N-[(1s,4s)-4-(2-chloro-5-fluoronicotinamido)cyclohexyl]carbamate 
• 247570-24-7 tert-butyl N-[(1s,4s)-4-aminocyclohexyl]carbamate 
• 38186-88-8 2-chloro-5-fluoronicotinic acid 
• 1196806-69-5 tert-butyl N-[(1s,4s)-4-[5-fluoro-2-(3-iodophenoxy)nicotinamido]cyclohexyl]carbamate 
• 1197291-10-3 N-((1s,4s)-4-(5-fluoro-2-(3-iodophenoxy)nicotinamido)cyclohexyl)-2-methylthiazole-4-carboxamide 
• 1197291-17-0 N-((1s,4s)-4-(5-fluoro-2-(4'-formylbiphenyl-3-yloxy)nicotinamido)cyclohexyl)-2-methylthiazole-4-carboxamide 
• 178312-62-4 homomorpholine hydrochloride 
• 76-05-1 trifluoroacetic acid 

Relevant articles and documents

Efficacious inhaled PDE4 inhibitors with low emetic potential and long duration of action for the treatment of COPD

Oral phosphodiesterase 4 (PDE4) inhibitors, such as cilomilast and roflumilast, have been shown to be efficacious against chronic obstructive pulmonary disease (COPD). However, these drugs have been hampered by mechanism-related side effects such as nause